Related Experiment Video
Updated: Sep 16, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
Impaired Autophagic Flux in Skeletal Muscle of Plectin-Related Epidermolysis Bullosa Simplex With Muscular Dystrophy
Michaela M Zrelski1, Margret Eckhard1, Petra Fichtinger1
1Division of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria.
Background:
Plectin, a multifunctional cytolinker and intermediate filament stabilizing protein, is essential for muscle fibre integrity and function. Mutations in the human plectin gene (PLEC) cause autosomal recessive epidermolysis bullosa simplex with muscular dystrophy (EBS-MD). The disorganization and aggregation of desmin filaments in conjunction with degenerative changes of the myofibrillar apparatus are key features in the skeletal muscle pathology of EBS-MD. We performed a comprehensive analysis addressing protein homeostasis in this rare protein aggregation disease by using human EBS-MD tissue, plectin knock-out mice and plectin-deficient cells.
Methods:
Protein degradation pathways were analysed in muscles from EBS-MD patients, muscle-specific conditional plectin knockout (MCK-Cre/cKO) mice, as well as in plectin-deficient (Plec-/-) myoblasts by electron and immunofluorescence microscopy. To obtain a comprehensive picture of autophagic processes, we evaluated the transcriptional regulation and expression levels of autophagic markers in plectin-deficient muscles and myoblasts (RNA-Seq, qRT-PCR, immunoblotting). Autophagic turnover was dynamically assessed by measuring baseline autophagy as well as specific inhibition and activation in mCherry-EGFP-LC3B-expressing Plec+/+ and Plec-/- myoblasts, and by monitoring primary Plec+/+ and Plec-/- myoblasts using organelle-specific dyes. Wild-type and MCK-Cre/cKO mice were treated with chloroquine or metformin to assess the effects of autophagy inhibition and activation in vivo.
Results:
Our study identified the accumulation of degradative vacuoles as well as LC3- and SQSTM1-positive patches in EBS-MD patients, MCK-Cre/cKO mouse muscles and Plec-/- myoblasts. The transcriptional regulation of ~30% of autophagy-related genes was altered, and protein levels of downstream targets of the autophagosomal degradation machinery were elevated in MCK-Cre/cKO muscle lysates (e.g., LAMP2, BAG3 and SQSTM1 to ~160, ~150 and ~140% of controls, respectively; p < 0.05). Autophagosome turnover was compromised in mCherry-EGFP-LC3B-expressing Plec-/- myoblasts (~40% reduction in median red:green ratio, reduced puncta number, smaller puncta; p < 0.01). By labelling autophagic compartments with CYTO-ID dye or lysosomes with LYSO-ID, we found reduced signal intensities in primary Plec-/- cells (p < 0.001). Treatment with chloroquine led to drastic swelling of autophagic vacuoles in primary Plec+/+ myoblasts, while the swelling in Plec-/- cells was moderate, establishing a defect in their autophagic clearance. Chloroquine treatment of MCK-Cre/cKO mice corroborated that loss of plectin coincides with impaired autophagic clearance, while metformin amelioratively induced autophagic flux.
Conclusions:
Our work demonstrates that the characteristic protein aggregation pathology in EBS-MD is linked to an impaired autophagic flux. The obtained results open a new perspective on the understanding of the protein aggregation pathology in plectin-related disorders and provide a basis for further pharmacological intervention.
Insights
Plectin deficiency impairs autophagy, leading to protein aggregation in epidermolysis bullosa simplex with muscular dystrophy (EBS-MD). This study reveals a link between plectin, autophagy, and muscle pathology, offering new therapeutic avenues.
Area of Science:
- Muscle biology
- Cellular biology
- Molecular genetics
Background:
- Plectin is crucial for muscle fiber integrity and intermediate filament stabilization.
- Mutations in the PLEC gene cause epidermolysis bullosa simplex with muscular dystrophy (EBS-MD), characterized by desmin filament disorganization and myofibrillar changes.
- Understanding protein homeostasis in EBS-MD is vital for this rare protein aggregation disease.
Purpose of the Study:
- To investigate the role of protein degradation pathways, specifically autophagy, in the skeletal muscle pathology of EBS-MD.
- To comprehensively analyze autophagic processes in plectin-deficient models and human tissues.
- To explore potential therapeutic targets for plectin-related disorders.
Main Methods:
- Analysis of protein degradation pathways and autophagic markers in human EBS-MD tissue, plectin knockout mice, and plectin-deficient cells using microscopy, RNA-Seq, qRT-PCR, and immunoblotting.
- Dynamic assessment of autophagic turnover using mCherry-EGFP-LC3B reporter cells and organelle-specific dyes.
- In vivo studies involving autophagy inhibition (chloroquine) and activation (metformin) in plectin-deficient mice.
Main Results:
- Accumulation of degradative vacuoles and autophagic markers (LC3, SQSTM1) observed in EBS-MD patients, plectin-deficient mice, and cells.
- Altered transcriptional regulation of autophagy-related genes and elevated levels of autophagosomal degradation targets.
- Compromised autophagosome turnover and impaired autophagic clearance in plectin-deficient models, with metformin showing ameliorative effects.
Conclusions:
- The protein aggregation pathology in EBS-MD is directly linked to impaired autophagic flux.
- This study provides novel insights into plectin-related protein aggregation disorders.
- Findings suggest autophagy modulation as a potential therapeutic strategy for EBS-MD.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Lysosomal Hydrolases

